NZ-804
NZ-804 is an orally active inhibitor for SARS-CoV-2 main protease Mpro with an IC50 of 8.9 nM. NZ-804 inhibits the SARS-CoV-2 replication in HeLa-hACE2 cell with an EC50 of 14 nM. NZ-804 exhibits board-spectrum antiviral activity aganst multiple CoVs. NZ-804 diminishes virus replication in mouse and hamster model[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV; Virus Protease
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(N1CC/C(CC1)=C2C3=C(CS(=O)(C4=C/2C=CC=C4)=O)C=CC=C3)C5=CN=CC6=C5NC=C6
Molecular Formula
C27H23N3O3S
Molecular Weight
469.55
References & Citations
[1]Zhou NE, et al., An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo. Cell Rep. 2024 Nov 26;43 (11) :114929.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-170309/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[2858658-44-1]
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1199901-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O139:H28 Bifunctional protein GlmU (glmU)
Ask
View Details MBS1199901-02 0.02 mg (Yeast)
Recombinant Escherichia coli O139:H28 Bifunctional protein GlmU (glmU)
Ask
View Details MBS1199901-03 0.1 mg (E-Coli)
Recombinant Escherichia coli O139:H28 Bifunctional protein GlmU (glmU)
Ask
View Details 
MBS1199901-04 0.1 mg (Yeast)
Recombinant Escherichia coli O139:H28 Bifunctional protein GlmU (glmU)
Ask
View Details